Bio-Rad Laboratories, Inc. (FRA:BUW)

Germany flag Germany · Delayed Price · Currency is EUR
250.00
+26.00 (11.61%)
At close: Feb 3, 2026
Market Cap6.17B -34.8%
Revenue (ttm)2.20B +0.7%
Net Income647.21M
EPS23.72
Shares Outn/a
PE Ratio9.54
Forward PE26.47
Dividendn/a
Ex-Dividend Daten/a
Volume5
Average Volume0
Open250.00
Previous Close224.00
Day's Range250.00 - 250.00
52-Week Range206.00 - 332.00
Betan/a
RSI85.00
Earnings DateFeb 12, 2026

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory e... [Read more]

Industry Laboratory Analytical Instruments
Founded 1952
Employees 7,450
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol BUW
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements